PACB 1.8 (+1.69%)
US69404D1081• Medical Diagnostics & Research• Diagnostics & Research
Intro Numbers Peers
  1. Home
  2. /
  3. All Stocks
  4. /
  5. PACB

Pacific Biosciences of California (PACB) Competitor Comparison

We are evaluating the key criteria listed to compare Pacific Biosciences of California (PACB) against its competitors in the Diagnostics & Research industry.

Market Capitalization

30 / 58

Gross Profits

38 / 52

Total Revenue

36 / 57

EBITDA

54 / 56

Free Cashflow

49 / 56

Quick Ratio

16 / 57

Earnings per Share

40 / 56

Dividend yield

0 / 9

Total Cash

11 / 57

Performance 3 years

53 / 58

Performance 5 years

43 / 58

Performance 10 years

40 / 58

Linearity 3 years

46 / 58

Linearity 5 years

15 / 58

Linearity 10 years

12 / 58

Total Rank

57 / 58

Dividend Rank

28 / 58

Valuation Rank

47 / 58

Piotroski Rank

54 / 58

Muliplier Rank

28 / 58

Muliplier Rank - PACB ranking 28 / 58

These are the competitors of Pacific Biosciences of California in the industry Diagnostics & Research ranked by muliplier rank
1. Global Cord Blood CO
1
2. Quest Diagnostics DGX
0.8
3. Laboratory Corp of America Holdings LH
0.8
4. Interpace Biosciences IDXG
0.6
5. Organovo Holdings ONVO
0.6
6. Ortho Clinical Diagnostics Holdings OCDX
0.6
7. IQVIA Holdings IQV
0.6
8. PerkinElmer PKI
0.6
9. bioAffinity Technologies BIAF
0.6
10. Qiagen QGEN
0.6
11. Syneos Health SYNH
0.6
12. Trinity Biotech TRIB
0.6
13. Inotiv NOTV
0.6
14. Exagen XGN
0.6
15. RadNet RDNT
0.6
16. Icon ICLR
0.6
17. Charles River Laboratories CRL
0.6
18. Illumina ILMN
0.6
19. Danaher DHR
0.5
20. Waters WAT
0.4
21. Fulgent Genetics FLGT
0.4
22. Psychemedics PMD
0.4
23. Thermo Fisher Scientific TMO
0.4
24. Neogen NEOG
0.2
25. NeoGenomics NEO
0.2
26. Neuronetics STIM
0.2
27. Olink Holding OLK
0.2
28. Pacific Biosciences of California PACB
0.2
29. Personalis PSNL
0.2
30. Precipio PRPO
0.2
31. Prenetics Global PRE
0.2
32. Agilent Technologies A
0.2
33. Sera Prognostics SERA
0.2
34. Sotera Health SHC
0.2
35. Twist Bioscience TWST
0.2
36. SeqLL SQL
0.2
37. Anixa Biosciences ANIX
0.2
38. Aspira Womens Health AWH
0.2
39. Biodesix BDSX
0.2
40. Bioventus BVS
0.2
41. CareDx CDNA
0.2
42. Co-Diagnostics CODX
0.2
43. DarioHealth DRIO
0.2
44. DexCom DXCM
0.2
45. Enzo Biochem ENZ
0.2
46. Exact Sciences EXAS
0.2
47. Guardant Health GH
0.2
48. Heska HSKA
0.2
49. IDEXX Laboratories IDXX
0.2
50. Lantheus Holdings LNTH
0.2
51. MaxCyte MXCT
0.2
52. MDxHealth MDXH
0.2
53. Medpace Holdings MEDP
0.2
54. Meridian Bioscience VIVO
0.2
55. Mettler-Toledo MTD
0.2
56. Myriad Genetics MYGN
0.2
57. Natera NTRA
0.2
58. National Research NRC
0.2
Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.